Literature DB >> 8583618

Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study.

B E Persson1, G Ronquist, M Ekblom.   

Abstract

PURPOSE: Nonbacterial prostatitis is a common problem in young men. It is a disease that is often recurrent and each episode lasts for several months. Different causative mechanisms of the disease have been discussed, including identified and unidentified microorganisms, stone formation and psychological factors. We have demonstrated in a previous study that urinary reflux (as shown by a high creatinine concentration in prostatic fluid) occurs to a varying extent into the prostatic ducts, and this reflux has been related to prostatic pain and urate concentration in expressed prostatic secretion.
MATERIALS AND METHODS: We performed a paralled double-blind controlled study of the objective and subjective effects of allopurinol on patients with nonbacterial prostatitis. Twenty patients received placebo, 18 received 300 mg. allopurinol daily and 16 received 600 mg allopurinol daily for 240 days. All patients began medication at the same time regardless of whether the disease was in an active state. No side effects were noted in the treatment groups.
RESULTS: Significant effects were noted on the concentrations of serum urate, urine urate, expressed prostatic secretion urate, expressed prostatic secretion xanthine and subjective discomfort.
CONCLUSIONS: Allopurinol has a significant, positive effect on nonbacterial prostatitis. It is safe and worthy of trial for all at least a 3-month period at each episode to relieve the symptoms of nonbacterial prostatitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8583618

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Interventions for chronic abacterial prostatitis.

Authors:  C McNaughton; R Mac Donald; T Wilt
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 2.  Chronic bacterial prostatitis and chronic pelvic pain syndrome.

Authors:  Diana K Bowen; Elodi Dielubanza; Anthony J Schaeffer
Journal:  BMJ Clin Evid       Date:  2015-08-27

3.  Chronic prostatitis.

Authors:  J A Stern; A J Schaeffer
Journal:  West J Med       Date:  2000-02

Review 4.  Chronic prostatitis.

Authors:  Brian Le; Anthony J Schaeffer
Journal:  BMJ Clin Evid       Date:  2011-07-04

5.  The New Age of Prostatitis.

Authors:  Granville L. Lloyd; Anthony J. Schaeffer
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

Review 6.  Chronic prostatitis.

Authors:  Bradley A Erickson; Anthony J Schaeffer; Brian Van Le
Journal:  BMJ Clin Evid       Date:  2008-05-22

Review 7.  An evidence-based approach to the treatment of prostatitis: is it possible?

Authors:  A Doble
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

Review 8.  [Psychosomatic aspects of the chronic pelvic pain syndrome].

Authors:  H J Berberich; M Ludwig
Journal:  Urologe A       Date:  2004-03       Impact factor: 0.639

9.  Tamsulosin Monotherapy versus Combination Therapy with Antibiotics or Anti-Inflammatory Agents in the Treatment of Chronic Pelvic Pain Syndrome.

Authors:  Tae Hyo Kim; Ki Soo Lee; Jeong Ho Kim; Joon Yeop Jee; Young Eun Seo; Dong Won Choi; Yeul Geun Sung; Geun Soo Kong; Dong Woo Kim; Won Yeol Cho
Journal:  Int Neurourol J       Date:  2011-06-30       Impact factor: 2.835

Review 10.  Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Juan Va Franco; Tarek Turk; Jae Hung Jung; Yu-Tian Xiao; Stanislav Iakhno; Federico Ignacio Tirapegui; Virginia Garrote; Valeria Vietto
Journal:  Cochrane Database Syst Rev       Date:  2019-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.